Most cited papers from Hokuriku University

Hokuriku University

What are the most cited papers from Hokuriku University?

The most cited paper from Hokuriku University is "Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application" (Naoki Asano, Robert J. Nash, Russell J. Molyneux et al., 2000), with 1,012 citations. Next come "Glycosidase inhibitors: update and perspectives on practical use" (718) and "Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury" (716).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 131 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application Naoki Asano, Robert J. Nash, Russell J. Molyneux et al. · Tetrahedron Asymmetry	May 2000	1,012
2	Glycosidase inhibitors: update and perspectives on practical use Naoki Asano · Glycobiology	10 Jun 2003	718
3	Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Hideto Yonekura, Yasuhiko Yamamoto, Shigeru Sakurai et al. · Biochemical Journal Open access	12 Mar 2003	716
4	Polyhydroxylated alkaloids — natural occurrence and therapeutic applications Alison A. Watson, George W. J. Fleet, Naoki Asano et al. · Phytochemistry	Feb 2001	708
5	Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor Jianqiang Fan, Satoshi Ishii, Naoki Asano et al. · Nature Medicine	1999	617
6	Favipiravir, an anti-influenza drug against life-threatening RNA virus infections Kimíyasu Shiraki, Tohru Daikoku · Pharmacology & Therapeutics Open access	22 Feb 2020	583
7	Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice Yasuhiko Yamamoto, Ichiro Kato, Toshio Doi et al. · Journal of Clinical Investigation Open access	15 Jul 2001	476
8	Polyhydroxylated Alkaloids Isolated from Mulberry Trees (Morus alba L.) and Silkworms (Bombyx mori L.) Naoki Asano, Toru Yamashita, Kayo Yasuda et al. · Journal of Agricultural and Food Chemistry	16 Aug 2001	389
9	Expression of short-chain fatty acid receptor GPR41 in the human colon Hideaki Tazoe, Yasuko Otomo, Shin-ichiro Karaki et al. · Biomedical Research Open access	2009	336
10	Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes Rongrong Jiang, Satoshi Yamaori, Shuso Takeda et al. · Life Sciences	26 Jun 2011	320
11	Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells Sho‐ichi Yamagishi, Yosuke Inagaki, Tamami Okamoto et al. · Journal of Biological Chemistry Open access	Jun 2002	312
12	N-containing sugars fromMorus alba and their glycosidase inhibitory activities Naoki Asano, Kengo Oseki, Emiko Tomioka et al. · Carbohydrate Research	Jun 1994	276
13	Atherosclerosis and Extracellular Matrix Shogo Katsuda, Toshiyuki Kaji · Journal of Atherosclerosis and Thrombosis Open access	2003	273
14	Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin Tamami Okamoto, Sho‐ichi Yamagishi, Yosuke Inagaki et al. · The FASEB Journal	4 Oct 2002	258
15	Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease Nobuyuki Sasaki, Sadamu Toki, Hiroshi Chowei et al. · Brain Research	2001	255
16	RAGE Control of Diabetic Nephropathy in a Mouse Model K.M. Myint, Yasuhiko Yamamoto, Toshio Doi et al. · Diabetes	25 Aug 2006	248
17	Convolutamydine A, a novel bioactive hydroxyoxindole alkaloid from marine bryozoan Amathia convoluta Yoshiaki Kamano, Huiping Zhang, Yoshitatsu Ichihara et al. · Tetrahedron Letters	Apr 1995	247
18	In vitro inhibition and intracellular enhancement of lysosomal α‐galactosidase A activity in Fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivatives Naoki Asano, Satoshi Ishii, Haruhisa Kizu et al. · European Journal of Biochemistry	Jul 2000	244
19	Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes Kazuhito Watanabe, Satoshi Yamaori, Tatsuya Funahashi et al. · Life Sciences	18 Jan 2007	239
20	Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Hisao Hayashi, Toshikuni Takikawa, N Nishimura et al. · PubMed	Jul 1994	228
21	Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety Satoshi Yamaori, Juri Ebisawa, Yoshimi Okushima et al. · Life Sciences	27 Feb 2011	223
22	Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease Masayoshi Takeuchi, Sho‐ichi Yamagishi · Current Pharmaceutical Design	Apr 2008	221
23	Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression Sho‐ichi Yamagishi, Kazuo Nakamura, Takanori Matsui et al. · Journal of Biological Chemistry Open access	18 May 2006	218
24	Sugars with nitrogen in the ring isolated from the leaves of Morus bombycis Naoki Asano, Emiko Tomioka, Haruhisa Kizu et al. · Carbohydrate Research	Feb 1994	213
25	Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal Pericytes Sho‐ichi Yamagishi, Shinjiro Amano, Yosuke Inagaki et al. · Biochemical and Biophysical Research Communications	2002	211
26	Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2‐deficient mice Keigyou Yoh, Aki Hirayama, Kazusa Ishizaki et al. · Genes to Cells Open access	9 Oct 2008	207
27	Neurotoxicity of Advanced Glycation End-Products for Cultured Cortical Neurons Masayoshi Takeuchi, Richard Bucala, Takako Suzuki et al. · Journal of Neuropathology & Experimental Neurology	Dec 2000	202
28	Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19 Rongrong Jiang, Satoshi Yamaori, Yasuka Okamoto et al. · Drug Metabolism and Pharmacokinetics	2013	199
29	Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo Masayoshi Takeuchi, Zenji Makita, Richard Bucala et al. · Molecular Medicine Open access	Feb 2000	197
30	Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice Haruhiko Sugino, Takashi Futamura, Yasuhide Mitsumoto et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry	25 Dec 2008	196
31	Elevated levels of serum advanced glycation end products in patients with non‐alcoholic steatohepatitis Hideyuki Hyogo, Sho‐ichi Yamagishi, Keiko Iwamoto et al. · Journal of Gastroenterology and Hepatology	7 Jun 2007	192
32	Biological Properties of d - and l -1-Deoxyazasugars Atsushi Kato, Noriko Kato, Erika Kano et al. · Journal of Medicinal Chemistry Open access	18 Sep 2004	187
33	TAGE (Toxic AGEs) Theory in Diabetic Complications Takashi Sato, Mina Iwaki, Noriko Shimogaito et al. · Current Molecular Medicine	29 Apr 2006	183
34	Naturally Occurring Iminosugars and Related Compounds: Structure, Distribution, and Biological Activity Naoki Asano · Current Topics in Medicinal Chemistry	Feb 2003	181
35	Two genetic variants of CD38 in subjects with autism spectrum disorder and controls Toshio Munesue et al. · Neuroscience Research Open access	3 May 2010	176
36	Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression Yuji Ishibashi, Takanori Matsui, Masayoshi Takeuchi et al. · Biochemical and Biophysical Research Communications	23 Dec 2009	172
37	Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Sho‐ichi Yamagishi, Yosuke Inagaki, Shinjiro Amano et al. · Biochemical and Biophysical Research Communications	Aug 2002	171
38	Nitrogen-in-the-Ring Pyranoses and Furanoses: Structural Basis of Inhibition of Mammalian Glycosidases Naoki Asano, Kengo Oseki, Haruhisa Kizu et al. · Journal of Medicinal Chemistry Open access	Oct 1994	168
39	Valiolamine, a new .ALPHA.-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. Yukihiko Kameda, Naoki Asano, Michiyo Yoshikawa et al. · The Journal of Antibiotics Open access	1984	166
40	Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes Satoshi Yamaori, Mika Kushihara, Ikuo Yamamoto et al. · Biochemical Pharmacology	2 Feb 2010	164
41	Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's disease Philippe Compain, Olivier R. Martin, Charlotte Boucheron et al. · ChemBioChem	26 Jul 2006	163
42	Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH Yuki Kimura, Hideyuki Hyogo, Sho‐ichi Yamagishi et al. · Journal of Gastroenterology	29 Jan 2010	160
43	Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes Hiroyuki Unoki‐Kubota, Hideaki Bujo, Sho‐ichi Yamagishi et al. · Diabetes Research and Clinical Practice	14 Nov 2006	157
44	Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes Junnosuke Miura, Sho‐ichi Yamagishi, Yasuko Uchigata et al. · Journal of Diabetes and its Complications	30 Dec 2002	157
45	Use of floating alginate gel beads for stomach-specific drug delivery Yojiro Murata · European Journal of Pharmaceutics and Biopharmaceutics	Sep 2000	156
46	Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study Mitsuhiro Yoshita et al. · PLoS ONE Open access	20 Mar 2015	154
47	New polyhydroxylated pyrrolizidine alkaloids from Muscari armeniacum: structural determination and biological activity Naoki Asano, Hiroyo Kuroi, Kyoko Ikeda et al. · Tetrahedron Asymmetry	2000	151
48	Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6 Satoshi Yamaori, Yasuka Okamoto, Ikuo Yamamoto et al. · Drug Metabolism and Disposition	5 Aug 2011	150
49	Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells Sho‐ichi Yamagishi, Yosuke Inagaki, Tamami Okamoto et al. · Kidney International Open access	Feb 2003	150
50	Antihyperglycemic Effects of N-Containing Sugars from Xanthocercis zambesiaca, Morus bombycis, Aglaonema treubii, and Castanospermum australe in Streptozotocin-Diabetic Mice Hiroshi Nojima, Ikuko Kimura, Fujun Chen et al. · Journal of Natural Products	20 Feb 1998	149

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.